Revolutionary CAR T-cell therapy shows promise in reversing age-related metabolic dysfunction

study evaluates senolytic CAR T-cell therapy targeting uPAR-positive cells in aged mice, showing its effectiveness in mitigating age-related metabolic dysfunction and offering a potential long-lasting treatment for aging-associated conditions.

Galecto terminates development for its lead candidate – Pharmaceutical Technology

Galecto CEO stated, “Given the impact of the results from the GALACTIC-1 trial on our future plans, we are currently evaluating resource allocation with the

August 16, 2023

FDA declines to grant Amgen’s Lumakras full approval in lung cancer after negative advisory committee vote

The FDA rejected Amgen’s bid to convert Lumakras’ accelerated approval into a full approval in lung cancer, the biopharma company announced Tuesday morning, and has

December 27, 2023

Three-pronged combination immunotherapy shows promise for pancreatic cancer patients

Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the pancreatic cancer vaccine GVAX, the immune checkpoint therapy nivolumab and urelemab,

July 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.